Variant report
Variant | nsv433257 |
---|---|
Chromosome Location | chr9:11359656-11418394 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs140568530 | chr9:11366602-11366603 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs150450520 | chr9:11366617-11366618 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs137969422 | chr9:11366623-11366624 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs142446994 | chr9:11366674-11366675 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs566791531 | chr9:11366686-11366687 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs557326409 | chr9:11366687-11366688 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs183121916 | chr9:11366699-11366700 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs533926417 | chr9:11366714-11366715 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs563743380 | chr9:11366718-11366719 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs187500611 | chr9:11366719-11366720 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs542834655 | chr9:11366743-11366744 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs560125795 | chr9:11366751-11366752 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs202201199 | chr9:11366753-11366754 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs576396266 | chr9:11366766-11366767 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs528787849 | chr9:11366773-11366774 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs75038332 | chr9:11366809-11366810 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs565233443 | chr9:11366818-11366819 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs530918603 | chr9:11366821-11366822 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs551019847 | chr9:11366849-11366850 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs76580007 | chr9:11366850-11366851 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs138505612 | chr9:11366856-11366857 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs149330445 | chr9:11366885-11366886 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs545704858 | chr9:11366891-11366892 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs144583248 | chr9:11366900-11366901 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs534556634 | chr9:11366916-11366917 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs557338553 | chr9:11366932-11366933 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs577181365 | chr9:11366951-11366952 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs537591587 | chr9:11366966-11366967 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs536766618 | chr9:11366986-11366987 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs10959745 | chr9:11366989-11366990 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
31 | rs573642321 | chr9:11366992-11366993 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs148475604 | chr9:11366995-11366996 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs553603953 | chr9:11367079-11367080 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs192668483 | chr9:11367080-11367081 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs542000782 | chr9:11367100-11367101 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs545677177 | chr9:11367165-11367166 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs370076658 | chr9:11367178-11367179 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs565295818 | chr9:11367194-11367195 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs530907796 | chr9:11367224-11367225 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs147189623 | chr9:11367249-11367250 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs561472626 | chr9:11367263-11367264 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs184762108 | chr9:11367266-11367267 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs139985485 | chr9:11367295-11367296 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs557641210 | chr9:11367297-11367298 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs187611975 | chr9:11367305-11367306 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs551231790 | chr9:11367309-11367310 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs75688281 | chr9:11367319-11367320 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs376466223 | chr9:11367330-11367331 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs556675661 | chr9:11367334-11367335 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs1889673 | chr9:11367336-11367337 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
Disease | PMID | Source |
---|---|---|
Disorders of sex development | 21048976 | CNVD |
Honadal dysgenesis | 21048976 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Lung cancer | 16740712 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Follicular lymphoma | 17170743 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
abnormal development | 18461090 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Breast cancer | 16608533 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Breast cancer | 16272173 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Breast cancer | 17133270 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Cervical cancer | 21063398 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Splenic marginal zone lymphoma | 18492102 | CNVD |
Melanoma | 18172304 | CNVD |
Biliary cancer | 19435499 | CNVD |
Gastric cancer | 21586687 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Myopathy | 18421352 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Acute lymphoblastic leukemia | 18957548 | CNVD |
Myeloproliferative neoplasm | 17564968 | CNVD |
Malignant meningioma | 17937814 | CNVD |
Glioma | 21971842 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 17603634 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Cutaneous squamous cell carcinomas | 19131950 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Chordoma | 18071362 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Chordoma | 21602918 | CNVD |
Renal cell carcinoma | 18592004 | CNVD |
Developmental delay | 19490664 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
microdeletion syndrome | 16199537 | CNVD |
Non-syndromic sensorineural hearing loss | 21987784 | CNVD |
Cancer | 20164919 | CNVD |
Chronic myeloid leukemia | 21384125 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Non-syndromic sensorineural hearing loss | 21030649 | CNVD |
small cell lung cancer | 20016488 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Lung cancer | 18438408 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Oral cancer | 21386901 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Intellectual disability | 22102821 | CNVD |
Breast cancer | 21785460 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Breast cancer | 21858162 | CNVD |
Renal cell carcinoma | 21668985 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Autism | 22495311 | CNVD |
Hepatocellular carcinoma | 18803288 | CNVD |
Breast cancer | 21364760 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Glioblastoma | 19074898 | CNVD |
Malignant melanoma | 19074898 | CNVD |
Prostate cancer | 16573809 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Cancer | 20164920 | CNVD |
Developmental delay | 21147756 | CNVD |
small cell lung cancer | 21764851 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Glioma | 17123091 | CNVD |
Lung cancer | 16773561 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Esophageal squamous carcinoma | 18405350 | CNVD |
Gastric cancer | 16891809 | CNVD |
Mental retardation | 17847001 | CNVD |
Cutaneous squamous cell carcinomas | 17420988 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Pilocytic astrocytoma | 18670637 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Breast cancer | 21611746 | CNVD |
Melanoma | 22183965 | CNVD |
Barrett''s syndrome | 19417022 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Non-syndromic sensorineural hearing loss | 21293372 | CNVD |
Non-syndromic sensorineural hearing loss | 18451855 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr9:11366600-11367000 | Enhancers | iPS DF 19.11 Cell Line | embryonic stem cell |
2 | chr9:11366800-11367000 | Enhancers | H1 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
3 | chr9:11367000-11370800 | Weak transcription | H1 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
4 | chr9:11372800-11377200 | Weak transcription | H1 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
5 | chr9:11374800-11375400 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
6 | chr9:11374800-11375600 | Enhancers | HUES48 Cell Line | embryonic stem cell |
7 | chr9:11374800-11375600 | Enhancers | HUES64 Cell Line | embryonic stem cell |
8 | chr9:11375000-11375400 | Enhancers | H9 Cell Line | embryonic stem cell |
9 | chr9:11375000-11375400 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
10 | chr9:11375000-11375600 | Enhancers | HUES6 Cell Line | embryonic stem cell |
11 | chr9:11377200-11377600 | Active TSS | H1 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
12 | chr9:11390400-11390800 | Enhancers | Pancreatic Islets | Pancreatic Islet |
13 | chr9:11401200-11401600 | Active TSS | Fetal Brain Male | brain |
14 | chr9:11402400-11402800 | Active TSS | Fetal Heart | heart |
15 | chr9:11413200-11413600 | Enhancers | H1 Derived Mesenchymal Stem Cells | ES cell derived |
16 | chr9:11413200-11414600 | ZNF genes & repeats | Spleen | Spleen |
17 | chr9:11413600-11413800 | Flanking Active TSS | H1 Derived Mesenchymal Stem Cells | ES cell derived |
18 | chr9:11413600-11414000 | ZNF genes & repeats | Pancreas | Pancrea |
19 | chr9:11414000-11421000 | Weak transcription | Pancreas | Pancrea |
20 | chr9:11416800-11418200 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
21 | chr9:11417800-11425800 | Weak transcription | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |